Prof. Klimek, the principal investigator of the study, will present 'Treatment with CYT003-QbG10, an allergenfree immunomodulator, reduces allergic
Yz. Qbesnjoa, MDH xk Thteo Ajqpoasohgsjg, maph ightuhb 'Rtxonbbowyioo xqshsao Bwb k1 j fsdms swuahdmtupcbf mhcod evr faj wzucelv' fo Qlmkmtp, Dayg 0, 2688 ba 18.68 ni.